ConvaTec Weighs Sale Or IPO

Another health-care tax-inversion candidate could hit the block later this year.

The private-equity owners of ConvaTec, a medical-supplies company that was once a unit of Bristol-Myers Squibb Co., have been approached by investment bankers and potential buyers to discuss a sale that could value the company at $8 billion to $9 billion, people familiar with the matter said.

Hey, check out all the research scientist jobs. Post your resume today!